The markets opened higher with the Dow climbing 64 points to 18,291 as crude oil prices rose. Nasdaq gained 25 points to 5,014.
On the upside
Sage Therapeutics (Nasdaq: SAGE) reported positive results from a Phase 2 clinical trial of SAGE-547 to treat severe postpartum depression.
Seagate Technology (Nasdaq: STX) reported preliminary fourth quarter revenue that surpassed expectations and announced additional job cuts.
BioDelivery Systems' (Nasdaq: BDSI) opioid dependency treatment BUNOVAIL received preferred formulary status by a significant managed care provider.
On the downside
CytRx (Nasdaq: CYTR) reported disappointing initial results from a Phase 3 trial of aldoxorubicin to treat patients with relapsed or refractory soft tissue sarcomas.
Profit taking weighed down shares of Resolute Energy (NYSE: REN).
Investors locked in profits on BioLife Solutions (Nasdaq: BLFS).
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 gained 10 points to 2,147. Bitcoin added $1 to $645.
